GTM

INSIDER SELL

ZoomInfo Technologies Inc.

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)

6.5d↑+5.7%

as of 2026-07-31

News Summary

Negative

ZoomInfo beat Q2 earnings and raised FY2026 guidance, but a $650.5M goodwill impairment and active securities class action lawsuit materially overshadowed results. The company is pivoting to consumption-based pricing and launching GTM.AI with AI platform integrations, but litigation centers on allegations of misleading investors about AI product impact on customer retention, creating execution and legal risk.

Red flags

•$650.5M goodwill impairment charge in Q2 2026
•Active securities class action lawsuit (Tejeda v. ZoomInfo) alleging fraud over misrepresentation of AI product impact on customer retention
•Customer growth 'regressed' per disclosure
•Consensus analyst rating of 'Reduce' from 18 analysts covering the stock
•Stock highly volatile with sharp valuation gap; significant execution risk from restructuring and consumption-based pricing transition
•Multiple analyst downgrades in August (Citi to Sell, DA Davidson lowered target)

Insider Activity

Name	Title	Type	Shares	Price	Value	Filed	Src
McGrane Ashley	General Counsel and Corp Sec	SELL	16K	$4.16	$0.07M	2026-08-07	↗
O'Brien Michael Graham	CFO	SELL	5K	$4.00	$0.02M	2026-08-06	↗
McGrane Ashley	General Counsel and Corp Sec	SELL	997	$3.56	$0.00M	2026-08-04	↗
Roth James M	Chief Revenue Officer	SELL	21K	$2.98	$0.06M	2026-07-02	↗
McGrane Ashley	General Counsel and Corp Sec	SELL	2K	$2.98	$0.01M	2026-07-02	↗

Fund 13D/13G Filings (1)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

Fund	Form	∆ Shares	% of Class	Since Filing	Filed	Src
Glenview Capital	SC 13G/A	—	0.0%	-2.4% vs SPY -4.2% abs	2026-08-14	↗